Inspire HGNS denied as non-formulary by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for inspire hgns are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Issues a Non-Formulary Denial for Inspire HGNS

Inspire HGNS is an implantable neurostimulation device rather than a pharmaceutical, but UnitedHealthcare applies a formulary-equivalent coverage tier structure to durable medical equipment and implantable devices. A non-formulary denial typically means UHC does not list the device as a covered benefit under the patient's specific plan or benefit design, or it is classified in a tier that requires additional justification. This is distinct from a medical-necessity denial — it is a benefit-structure determination.

## Why This Denial Is Appealable

Non-formulary denials are routinely overturned through two pathways:

• Formulary exception / medical exception: Most plans must offer a process to cover a non-formulary item when there is no adequate covered alternative and the device is medically necessary for the patient's condition. The insurer's own Summary of Benefits and Coverage (SBC) and Evidence of Coverage (EOC) will describe this process.
• Federal appeal rights: Under ACA §2719 and ERISA §503, you retain full internal and external appeal rights. After an adverse benefit determination, request an internal appeal, then external review if the internal appeal is denied. The external-review window is generally within four months of the final internal denial, and the reviewer's decision is binding.
• Expedited review is available when the patient's condition cannot wait for standard timelines.

## Documentation to Gather

1. Plan documents: Pull the patient's Summary of Benefits and Coverage and Evidence of Coverage to identify the exact language governing coverage of implantable devices and the exception process. 2. Absence of adequate alternatives: The prescriber should document — with specificity drawn from the chart — why covered alternatives (such as CPAP or other positive airway pressure devices) are inadequate or not tolerated for this patient. 3. Diagnosis and severity: Sleep study results interpreted by a qualified specialist, confirming the diagnosis and severity level. 4. Medical-necessity letter: The ordering physician and specialist should co-author a letter explaining why Inspire HGNS is medically necessary and why no covered device meets this patient's clinical needs. 5. FDA clearance and guideline organization support: Note that the device holds FDA clearance for its indicated use, and reference that the applicable specialist society guideline organizations support its use in appropriately selected patients — without citing specific numbers or statistics.

## Criteria-Mapping Structure

For a non-formulary exception, structure the argument around the plan's exception criteria rather than a clinical coverage policy:

| Exception Requirement (from EOC/SBC) | Chart and Clinical Evidence | |---|---| | [Copy each exception criterion from the plan document] | [Specific chart finding, date, and prescriber attestation] |

A well-organized exception request that directly mirrors the plan's own language for exceptions is far more likely to succeed than a general letter. Obtain UHC's current published medical policy for hypoglossal nerve stimulation and the FDA-approved labeling to confirm the device's approved indication, and cite both in the appeal.